A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Reacting to the findings of the trials, which have been published in the journal Nature, Claire Bale, associate director of ...

The phase I clinical trials showed stem cell transplants for Parkinson’s disease appear to be safe and might restore dopamine-producing brain cells.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might ...

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

Hebrew University researchers say their innovative test can find tRNA fragments unique to the neurodegenerative disease ...

A groundbreaking open-source computer program uses artificial intelligence to analyze videos of patients with Parkinson's disease and other movement disorders. The tool, called VisionMD, helps doctors ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

In a new Cedars-Sinai study of Parkinson's disease patients, those who had taken common medications to control pain, blood ...